tiprankstipranks
iX Biopharma Ltd. (SG:42C)
SGX:42C
Singapore Market
Holding SG:42C?
Track your performance easily

iX Biopharma Ltd. (42C) Income Statement

6 Followers

iX Biopharma Ltd. Income Statement

Last quarter (Q4 2021), iX Biopharma Ltd.'s total revenue was S$―, a decrease of -100.00% from the same quarter last year. In Q4, iX Biopharma Ltd.'s net income was S$―. See iX Biopharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 21Jun 20Jun 19Jun 18Jun 17
Total Revenue
S$ 294.00KS$ 1.75MS$ 985.00KS$ 671.00KS$ 246.00KS$ 6.38M
Cost of Revenue
S$ 689.00KS$ 2.13MS$ 1.57MS$ 1.20MS$ 493.00KS$ 4.14M
Gross Profit
S$ -395.00KS$ -382.00KS$ -587.00KS$ -529.00KS$ -247.00KS$ 2.24M
Operating Expense
S$ 5.52MS$ 9.70MS$ 10.45MS$ 11.39MS$ 14.20MS$ 10.81M
Operating Income
S$ -5.92MS$ -10.08MS$ -11.04MS$ -11.91MS$ -14.45MS$ -8.57M
Net Non Operating Interest Income Expense
S$ -119.00KS$ -167.00KS$ -151.00KS$ -38.00KS$ -27.00KS$ -106.00K
Other Income Expense
------
Pretax Income
S$ -5.76MS$ -8.23MS$ -10.50MS$ -13.27MS$ -15.23MS$ -7.58M
Tax Provision
-S$ 1.00KS$ 0.00S$ -22.00KS$ 52.00KS$ -191.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
S$ -5.76MS$ -8.23MS$ -10.50MS$ -2.99MS$ -15.09MS$ -7.39M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
S$ 6.21MS$ 11.82MS$ 12.02MS$ 12.59MS$ 14.70MS$ 14.95M
Net Income From Continuing And Discontinued Operation
S$ -5.76MS$ -8.23MS$ -10.50MS$ -2.99MS$ -15.09MS$ -7.39M
Normalized Income
S$ -5.76MS$ -8.23MS$ -10.50MS$ -13.25MS$ -15.29MS$ -7.39M
Interest Expense
S$ 119.00KS$ 174.00KS$ 238.00KS$ 232.00KS$ 250.00KS$ 242.00K
EBIT
S$ -5.65MS$ -8.06MS$ -10.26MS$ -13.04MS$ -14.98MS$ -7.34M
EBITDA
S$ -5.13MS$ -7.00MS$ -9.21MS$ -11.82MS$ -13.58MS$ -6.06M
Currency in SGD

iX Biopharma Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis